JinCheng Guo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

JinCheng Guo

Showing results (81-90 of 82) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 82 results.

BMC Medicine|November 19, 2025

Dabigatran-based versus warfarin-based triple antithrombotic regimen with a 1-month intensification after coronary stenting in patients with nonvalvular atrial fibrillation (COACH-AF PCI)Ming Liang, Jun Jin, Ruiping Zhao, et al.

Journal of Diabetes|August 3, 2018

Safety and efficacy of zotarolimus-eluting stents in the treatment of diabetic coronary lesions in Chinese patients: The RESOLUTE-DIABETES CHINA StudyZhengbin Zhu, Yongjian Wu, Zhujun Shen, et al.

Pageof 9

Search research articles

Showing results (81-90 of 82) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 82 results.

BMC Medicine|November 19, 2025

Dabigatran-based versus warfarin-based triple antithrombotic regimen with a 1-month intensification after coronary stenting in patients with nonvalvular atrial fibrillation (COACH-AF PCI)Ming Liang, Jun Jin, Ruiping Zhao, et al.

Journal of Diabetes|August 3, 2018

Safety and efficacy of zotarolimus-eluting stents in the treatment of diabetic coronary lesions in Chinese patients: The RESOLUTE-DIABETES CHINA StudyZhengbin Zhu, Yongjian Wu, Zhujun Shen, et al.

Pageof 9